SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $170K invested in Salarius Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.7K
2
+$10.8K
3
+$8.45K
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.47K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$156

Top Sellers

1
-$89.1K
2
-$858
3
-$78
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$32
5
BlackRock
BlackRock
New York
-$31
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$57.2K
2
$20.2K
3
$19.5K
4
$17K
5
$15.9K
6
$15.7K
7
$9.47K
8
$8.45K
9
$5.32K
10
$900
11
$78
12
$51
13
$31
14
$21
15
$20
16
$10